Literature DB >> 15337829

Cu,Zn-superoxide dismutase is lower and copper chaperone CCS is higher in erythrocytes of copper-deficient rats and mice.

Elizabeth C West1, Joseph R Prohaska.   

Abstract

Discovery of a sensitive blood biochemical marker of copper status would be valuable for assessing marginal copper intakes. Rodent models were used to investigate whether erythrocyte concentrations of copper,zinc-superoxide dismutase (SOD), and the copper metallochaperone for SOD (CCS) were sensitive to dietary copper changes. Several models of copper deficiency were studied in postweanling male Holtzman rats, male Swiss Webster mice offspring, and both rat and mouse dams. Treatment resulted in variable but significantly altered copper status as evaluated by the presence of anemia, and lower liver copper and higher liver iron concentrations in copper-deficient compared with copper-adequate animals. Associated with this copper deficiency were consistent reductions in immunoreactive SOD and robust enhancements in CCS. In most cases, the ratio of CCS:SOD was several-fold higher in red blood cell extracts from copper-deficient compared with copper-adequate rodents. Determination of red cell CCS:SOD may be useful for assessing copper status of humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15337829     DOI: 10.1177/153537020422900807

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  22 in total

1.  Peripheral nerve and brain differ in their capacity to resolve N,N-diethyldithiocarbamate-mediated elevations in copper and oxidative injury.

Authors:  Holly L Valentine; Olga M Viquez; William M Valentine
Journal:  Toxicology       Date:  2010-05-07       Impact factor: 4.221

2.  Interactions of cisplatin and the copper transporter CTR1 in human colon cancer cells.

Authors:  Mia C Akerfeldt; Carmen M-N Tran; Clara Shen; Trevor W Hambley; Elizabeth J New
Journal:  J Biol Inorg Chem       Date:  2017-05-17       Impact factor: 3.358

3.  Cardiac copper deficiency activates a systemic signaling mechanism that communicates with the copper acquisition and storage organs.

Authors:  Byung-Eun Kim; Michelle L Turski; Yasuhiro Nose; Michelle Casad; Howard A Rockman; Dennis J Thiele
Journal:  Cell Metab       Date:  2010-05-05       Impact factor: 27.287

Review 4.  Metabolic crossroads of iron and copper.

Authors:  James F Collins; Joseph R Prohaska; Mitchell D Knutson
Journal:  Nutr Rev       Date:  2010-03       Impact factor: 7.110

Review 5.  Posttranslational modifications in Cu,Zn-superoxide dismutase and mutations associated with amyotrophic lateral sclerosis.

Authors:  Yoshiaki Furukawa; Thomas V O'Halloran
Journal:  Antioxid Redox Signal       Date:  2006 May-Jun       Impact factor: 8.401

Review 6.  Exploring the Extended Biological Functions of the Human Copper Chaperone of Superoxide Dismutase 1.

Authors:  Yan Ge; Lu Wang; Duanhua Li; Chen Zhao; Jinjun Li; Tao Liu
Journal:  Protein J       Date:  2019-08       Impact factor: 2.371

7.  The mammalian phosphate carrier SLC25A3 is a mitochondrial copper transporter required for cytochrome c oxidase biogenesis.

Authors:  Aren Boulet; Katherine E Vest; Margaret K Maynard; Micah G Gammon; Antoinette C Russell; Alexander T Mathews; Shelbie E Cole; Xinyu Zhu; Casey B Phillips; Jennifer Q Kwong; Sheel C Dodani; Scot C Leary; Paul A Cobine
Journal:  J Biol Chem       Date:  2017-12-13       Impact factor: 5.157

8.  Variable response of selected cuproproteins in rat choroid plexus and cerebellum following perinatal copper deficiency.

Authors:  Anna A Gybina; Joseph R Prohaska
Journal:  Genes Nutr       Date:  2006-03       Impact factor: 5.523

9.  Fructose-2,6-bisphosphate is lower in copper deficient rat cerebellum despite higher content of phosphorylated AMP-activated protein kinase.

Authors:  Anna A Gybina; Joseph R Prohaska
Journal:  Exp Biol Med (Maywood)       Date:  2008-08-14

10.  Copper deficiency results in AMP-activated protein kinase activation and acetylCoA carboxylase phosphorylation in rat cerebellum.

Authors:  Anna A Gybina; Joseph R Prohaska
Journal:  Brain Res       Date:  2008-02-13       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.